Form 4: Director Frank D. Lee Sells Bausch Health Shares

Director Frank D. Lee sold 24,456 shares of Bausch Health Companies Inc. to cover tax obligations related to vested equity awards.

Summary

• Director Frank D. Lee sold 24,456 common shares of Bausch Health Companies Inc. (BHC).
• The transaction occurred on May 19, 2026, at a price of $5.43 per share.
• The sale was executed pursuant to a pre-established Rule 10b5-1 trading plan.
• Following the transaction, the director retains beneficial ownership of 49,339 shares.
• The proceeds from the sale are intended to satisfy tax obligations arising from previously vested equity awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale is explicitly linked to tax obligations via a pre-planned trading arrangement.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which is a standard mechanism for orderly divestment.

Negatives

• The transaction represents a reduction in the director's direct equity stake in the company.

Risks

• None identified beyond standard market risks associated with equity ownership.

Future Outlook

No forward-looking guidance provided in this filing.

Management Comments

• The sale was executed to fund estimated tax obligations arising from a previously vested equity award.

Industry Context

StockSavvy.ai notes that insider sales to cover tax liabilities are routine corporate governance events and generally do not signal a change in management's outlook on the company's long-term prospects.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a standard industry practice for corporate insiders to avoid potential conflicts of interest or accusations of trading on non-public information.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and limited in scope.

Next Steps

• None specified.

Key Dates

Keywords

Bausch Health, BHC, Insider Trading, Form 4, Equity Sale, Director Transaction